We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Leptin Associated with Poor Thyroid Cancer Prognosis

By LabMedica International staff writers
Posted on 14 Oct 2009
Leptin, a molecule linked with obesity, predicted poor prognosis from thyroid cancer in Saudi Arabia.

Scientists measured the level of leptin and its receptor in 536 human thyroid cancer samples. More...
They found that over expression of the leptin receptor was significantly associated with poor disease survival in 80% of the cases. Increased leptin receptor expression was linked with older age, larger tumor size, advanced stage, and metastasis. The scientists also demonstrated in laboratory in vitro experiments that leptin stimulated growth of thyroid cancer cells and prevented their death.

"Leptin receptor expression may be a useful molecular marker in predicting the level of aggression of Middle Eastern thyroid cancer that can help guide treatment options and follow-up care," said lead scientist Khawla S. Al-Kuraya, M.D., director of the research center at King Faisal Specialist Hospital and Research Center (Riyadh, Saudi Arabia). Leptin receptor status can be easily assessed with a fine needle biopsy, according to Dr. Al-Kuraya.

Whereas thyroid cancer is the eighth most common cancer among American women, it is the second most common in Saudi Arabian women. This high prevalence is seen in all Gulf Council countries, according to Dr. Al-Kuraya.

The data were presented at the American Association for Cancer Research Frontiers in Basic Cancer Research Meeting, held in Boston (USA) from Oct. 8-11, 2009.

Related Links:
King Faisal Specialist Hospital and Research Center




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Researchers have developed the first ever test for early detection of multiple sclerosis (Photo courtesy of 123RF)

Blood Test Detects Multiple Sclerosis Risk Years Before Onset of Symptoms

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that affects around 2.8 million people worldwide. Its development is linked to immunological processes triggered... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.